Vincenzo Cerullo

Associate professor

  • PL 56 (Viikinkaari 5)

    00014

    Finland

20022019
Om du gjort några ändringar i Pure kommer de visas här snart.

Publikationer 2002 2019

2019

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

Fontana, F., Fusciello, M., Groeneveldt, C., Capasso, C., Chiaro, J., Feola, S., Liu, Z., Mäkilä, E., Salonen, J., Hirvonen, J., Cerullo, V. & Santos, H. A., jun 2019, I : ACS Nano. 13, 6, s. 6477-6490 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice

Garofalo, M., Villa, A., Rizzi, N., Kuryk, L., Rinner, B., Cerullo, V., Yliperttula, M., Mazzaferro, V. & Ciana, P., 28 jan 2019, I : Journal of Controlled Release. 294, s. 165-175 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice

Leggiero, E., Labruna, G., Iaffaldano, L., Lombardo, B., Greco, A., Fiorenza, D., Gramanzini, M., Montanaro, D., Baldi, A., Cerullo, V., Sacchetti, L. & Pastore, L., apr 2019, I : Gene Therapy (Basingstoke). 26, 3-4, s. 121-130 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

Lopes, A., Feola, S., Ligot, S., Fusciello, M., Vandermeulen, G., Préat, V. & Cerullo, V., 10 jul 2019, I : Journal for Immunotherapy of Cancer. 7, 1

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks

Kuryk, L., Moller, A-S. W., Vuolanto, A., Pesonen, S., Garofalo, M., Cerullo, V. & Jaderberg, M., 1 feb 2019, I : International Journal of Molecular Sciences. 20, 3, 15 s., 621.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2018

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

Garofalo, M., Saari, H., Somersalo, P., Crescenti, D., Kuryk, L., Aksela, L., Capasso, C., Madetoja, M., Koskinen, K., Oksanen, T., Mäkitie, A., Jalasvuori, M., Cerullo, V., Ciana, P. & Yliperttula, M., 1 jun 2018, I : Journal of Controlled Release. 283, s. 223-234 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model

Kuryk, L., Moller, A-S. W., Garofalo, M., Cerullo, V., Pesonen, S., Alemany, R. & Jaderberg, M., okt 2018, I : Journal of Medical Virology. 90, 10, s. 1669-1673 5 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System

Cerullo, V., Capasso, C., Vähä-Koskela, M., Hemminki, O. & Hemminki, A., 2018, I : Current Cancer Drug Targets. 18, 2, s. 124-138 15 s.

Forskningsoutput: TidskriftsbidragÖversiktsartikelVetenskapligPeer review

Development of Biohybrid Multistage Nanovaccines for Melanoma

Fontana, F., Capasso, C., Shahbazi, M-A., Liu, D., Fusciello, M., Feola, S., Zhang, H., Mäkilä, E., Salonen, J., Hirvonen, J. T., Cerullo, V. & Almeida Santos, H., 2018, (!!Accepted/In press).

Forskningsoutput: KonferensbidragSammanfattningForskningPeer review

Oncolytic Adenoviruses Encapsulated into the Extracellular Vesicles as Carriers for Cancer Drug Delivery

Garofalo, M., Saari, H., Somersalo, P., Crescenti, D., Kuryk, L., Aksela, L., Capasso, C., Madetoja, M., Koskinen, K., Makitie, A., Jalasvuori, M., Cerullo, V., Ciana, P. & Yliperttula, M., maj 2018, I : Molecular therapy. 26, 5, s. 203-203 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Feola, S., Capasso, C., Fusciello, M., Martins, B., Tähtinen, S., Medeot, M., Carpi, S., Frascaro, F., Ylösmaki, E., Peltonen, K., Pastore, L. & Cerullo, V., 2018, I : OncoImmunology. 7, 8, 10 s., 1457596.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Ylösmäki, E., Malorzo, C., Capasso, C., Honkasalo, O., Fusciello, M., Martins, B., Ylösmäki, L., Louna, A., Feola, S., Paavilainen, H., Peltonen, K., Hukkanen, V., Viitala, T. & Cerullo, V., 5 sep 2018, I : Molecular therapy. 26, 9, s. 2315-2325 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2017

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma

Capasso, C., Magarkar, A., Cervera-Carascon, V., Fusciello, M., Feolaf, S., Muller, M., Garofalo, M., Kuryk, L., Tahtinen, S., Pastore, L., Bunker, A. & Cerullo, V., 2017, I : OncoImmunology. 6, 9, 14 s., 1319028.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Biohybrid Nanovaccines in Murine Melanoma: Efficacy and Synergistic Combo Therapy with Immune Checkpoint Inhibitor

Fontana, F., Capasso, C., Fusciello, M., Feola, S., Mäkilä, E., Salonen, J., Hirvonen, J. T., Cerullo, V. & Almeida Santos, H., 2017.

Forskningsoutput: KonferensbidragSammanfattningForskningPeer review

Homology between cancer and viral epitopes as criteria to design improved cancer vaccines

Capasso, C., Whalley, T., Marwah, V. S., Serafin, A., Fusciello, M., Feola, S., Martins, B., Greco, D., Szomolay, B. & Cerullo, V., dec 2017, I : Annals of Oncology. 28, 1 s., 63P.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles

Lazaro Ibañez, E., Neuvonen, K. M., Takatalo-Laine, S. M., Thanigai Arasu, U., Capasso, C., Cerullo, V., Rhim, J., Rilla, K., Yliperttula, M. L. & Siljander, P. R-M., 10 aug 2017, I : Journal of Extracellular Vesicles.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Thiol-ene surface modifications for microchip electrophoresis based interaction assays

Tähkä, S., Batelic, L., Capasso, C., Wiedmer, S. K., Cerullo, V. & Sikanen, T. M., okt 2017, s. 1535-1536. 2 s.

Forskningsoutput: KonferensbidragSammanfattningForskningPeer review

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment

Kuryk, L., Vassilev, L., Ranki, T., Hemminki, A., Karioja-Kallio, A., Levälampi, O., Vuolanto, A., Cerullo, V. & Pesonen, S., 10 aug 2017, I : PLoS One. 12, 8, 15 s., 0182715.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2016

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Taipale, K., Liikanen, I., Juhila, J., Turkki, R., Tahtinen, S., Kankainen, M., Vassilev, L., Ristimaki, A., Koski, A., Kanerva, A., Diaconu, I., Cerullo, V., Vaha-Koskela, M., Oksanen, M., Linder, N., Joensuu, T., Lundin, J. & Hemminki, A., jan 2016, I : Molecular therapy. 24, 1, s. 175-183 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity

Hirvinen, M., Capasso, C., Guse, K., Garofalo, M., Vitale, A., Ahonen, M., Kuryk, L., Vähä-Koskela, M., Hemminki, A., Fortino, V., Greco, D. & Cerullo, V., 23 mar 2016, I : Molecular Therapy - Oncolytics. 3, 9 s., 16002.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the anti-tumor immunity and efficacy against melanoma

Capasso, C., Hirvinen, M., Garofalo, M., Romaniuk, D., Kuryk, L., Sarvela, T., Vitale, A., Antopolsky, M., Magarkar, A., Viitala, T., Suutari, T., Bunker, A., Yliperttula, M., Urtti, A. & Cerullo, V., 2016, I : OncoImmunology. 5, 4, 11 s., 1105429.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

Garofalo, M., Iovine, B., Kuryk, L., Capasso, C., Hirvinen, M., Vitale, A., Yliperttula, M., Bevilacqua, M. A. & Cerullo, V., apr 2016, I : Molecular Cancer Therapeutics. 15, 4, s. 651-660 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model

Kuryk, L., Haavisto, E., Garofalo, M., Capasso, C., Hirvinen, M., Pesonen, S., Ranki, T., Vassilev, L. & Cerullo, V., 15 okt 2016, I : International Journal of Cancer. 139, 8, s. 1883-1893 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes

Ruan, M. Z. C., Cerullo, V., Cela, R., Clarke, C., Lundgren-Akerlund, E., Barry, M. A. & Lee, B. H. L., 2016, I : Molecular therapy-Methods & clinical development. 3, 8 s., 16008.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2015

GMCSF-armed vaccinia virus induces an antitumor immune response

Parviainen, S., Ahonen, M., Diaconu, I., Kipar, A., Siurala, M., Vaha-Koskela, M., Kanerva, A., Cerullo, V. & Hemminki, A., 1 mar 2015, I : International Journal of Cancer. 136, 5, s. 1065-1072 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus

Hirvinen, M., Rajecki, M., Kapanen, M., Parviainen, S., Rouvinen-Lagerstrom, N., Diaconu, I., Nokisalmi, P., Tenhunen, M., Hemminki, A. & Cerullo, V., 1 mar 2015, I : Human Gene Therapy. 26, 3, s. 134-144 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

New oncolytic vaccine platform enhance anti-tumor immunity in humanized mice with human melanomas

Capasso, C., Hirvinen, M., Garofalo, M., Romaniuk, D., Kuryk, L., Sarvela, T., Vitale, A., Antopolsky, M., Magarkar, A., Viitala, T., Suutari, T., Bunker, A., Yliperttula, M., Urtti, A. & Cerullo, V., 1 okt 2015, I : Human Gene Therapy. 26, 10, s. A53-A53 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma

Siurala, M., Bramante, S., Vassilev, L., Hirvinen, M., Parviainen, S., Tahtinen, S., Guse, K., Cerullo, V., Kanerva, A., Kipar, A., Vaha-Koskela, M. & Hemminki, A., 15 feb 2015, I : International Journal of Cancer. 136, 4, s. 945-954 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic viruses for treatment of cancer

Hemminki, A., Vähä-Koskela, M. & Cerullo, V., 20 jan 2015, Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fourth Edition. Smyth Templeton, N. (red.). 4 red. Taylor & Francis/CRC Press, s. 185-200 16 s.

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Vaha-Koskela, M., Tahtinen, S., Gronberg-Vaha-Koskela, S., Taipale, K., Saha, D., Merisalo-Soikkeli, M., Ahonen, M., Rouvinen-Lagerstrom, N., Hirvinen, M., Veckman, V., Matikainen, S., Zhao, F., Pakarinen, P., Salo, J., Kanerva, A., Cerullo, V. & Hemminki, A., 7 jan 2015, I : Molecular Therapy - Oncolytics. 2, 9 s., 14006.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex

D'Errico, S., Oliviero, G., Borbone, N., Di Gennaro, E., Zotti, A. I., Budillon, A., Cerullo, V., Nici, F., Mayol, L., Piccialli, V. & Piccialli, G., dec 2015, I : European Journal of Organic Chemistry. 34, s. 7550-7556 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Bramante, S., Kaufmann, J. K., Veckman, V., Liikanen, I., Nettelbeck, D. M., Hemminki, O., Vassilev, L., Cerullo, V., Oksanen, M., Heiskanen, R., Joensuu, T., Kanerva, A., Pesonen, S., Matikainen, S., Vaha-Koskela, M., Koski, A. & Hemminki, A., 1 okt 2015, I : International Journal of Cancer. 137, 7, s. 1775-1783 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2014

Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors

Nishio, N., Diaconu, I., Liu, H., Cerullo, V., Caruana, I., Hoyos, V., Bouchier-Hayes, L., Savoldo, B. & Dotti, G., 15 sep 2014, I : Cancer Research. 74, 18, s. 5195-5205 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

Parviainen, S., Ahonen, M., Diaconu, I., Hirvinen, M., Karttunen, A., Vähä-Koskela, M., Hemminki, A. & Cerullo, V., feb 2014, I : Gene Therapy (Basingstoke). 21, 2, s. 195-204 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy

Farzad, L., Cerullo, V., Yagyu, S., Bertin, T., Hemminki, A., Rooney, C., Lee, B. & Suzuki, M., 2014, I : Molecular Therapy - Oncolytics. 1, 9 s., 14008.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

Hemminki, O., Immonen, R., Narvainen, J., Kipar, A., Paasonen, J., Jokivarsi, K. T., Yli-Ollila, H., Soininen, P., Partanen, K., Joensuu, T., Parvianen, S., Koski, A., Vähä-Koskela, M., Cerullo, V., Pesonen, S., Grohn, O. H. & Hemminki, A., 15 jun 2014, I : International Journal of Cancer. 134, 12, s. 2878-2890 13 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Bramante, S., Koski, A., Kipar, A., Diaconu, I., Liikanen, I., Hemminki, O., Vassilev, L., Parviainen, S., Cerullo, V., Pesonen, S. K., Oksanen, M., Heiskanen, R., Rouvinen-Lagerstroem, N., Merisalo-Soikkeli, M., Hakonen, T., Joensuu, T., Kanerva, A-M., Pesonen, S. & Hemminki, A., 1 aug 2014, I : International Journal of Cancer. 135, 3, s. 720-730 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications

Capasso, C., Garofalo, M., Hirvinen, M. & Cerullo, V., feb 2014, I : Viruses. 6, 2, s. 832-855 24 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Translational Cancer Research

Cerullo, V., Guse, K., Vähä-Koskela, M. & Hemminki, A. E., 2014, Cancer Gene Therapy by Viral and Non-viral Vectors. Brenner, M. & Hung, M-C. (red.). Wiley, s. 3-20 18 s. (Translational oncology; nr. 4).

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors

Cerullo, V., Guse, K., Vaha-Koskela, M. & Hemminki, A., 2014, Cancer Gene Therapy by Viral and Non-Viral Vectors. Brenner, MK. & Hung, MC. (red.). Oxford: Blackwell Science, s. 3-20 18 s. ( Translational Oncology-Hoboken).

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

Virus Wars Oncolytic versus Oncogenic Viruses

Vaha-Koskela, M., Le Boeuf, F. & Cerullo, V., 2014, CANCER-CAUSING VIRUSES AND THEIR INHIBITORS. Gupta, SP. (red.). Bica Raton: Taylor & Francis/CRC Press, s. 407-436 30 s.

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKapitelVetenskapligPeer review

2013

Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus

Kanerva, A., Nokisalmi, P., Diaconu, I., Koski, A., Cerullo, V., Liikanen, I., Tahtinen, S., Oksanen, M., Heiskanen, R., Pesonen, S., Joensuu, T., Alanko, T., Partanen, K., Laasonen, L., Kairemo, K., Pesonen, S., Kangasniemi, L. & Hemminki, A., 15 maj 2013, I : Clinical Cancer Research. 19, 10, s. 2734-2744 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors

Capasso, C., Hirvinen, M. & Cerullo, V., 4 dec 2013, I : Biomedicines. 1, 1, s. 3-16 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

Hirvinen, M., Heiskanen, R., Oksanen, M., Pesonen, S., Liikanen, I., Joensuu, T., Kanerva, A., Cerullo, V. & Hemminki, A., 21 aug 2013, I : Journal of Translational Medicine. 11, Article Number: 193, 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Genetic diversity and tumor immunesurveillance

Hirvinen, M. & Cerullo, V., feb 2013, I : Journal of thoracic disease. 5, 1, s. 6-7 2 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients

Liikanen, I., Ahtiainen, L., Hirvinen, M. L. M., Bramante, S., Cerullo, V., Nokisalmi, P., Hemminki, O., Diaconu, I., Pesonen, S., Koski, A., Kangasniemi, L., Pesonen, S. K., Oksanen, M., Laasonen, L., Partanen, K., Joensuu, T., Zhao, F., Kanerva, A. & Hemminki, A., jun 2013, I : Molecular therapy. 21, 6, s. 1212-1223 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice

Leggiero, E., Astone, D., Cerullo, V., Lombardo, B., Mazzaccara, C., Labruna, G., Sacchetti, L., Salvatore, F., Croyle, M. & Pastore, L., 2013, I : Gene Therapy (Basingstoke). 20, 12, s. 1124-1130 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2012

Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

Hemminki, O., Diaconu, I., Cerullo, V., Pesonen, S. K., Kanerva, A-M., Joensuu, T., Kairemo, K., Laasonen, L., Partanen, K., Kangasniemi, L., Lieber, A., Pesonen, S. & Hemminki, A., 1 sep 2012, I : Molecular therapy. 20, 9, s. 1821-1830 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance

Cerullo, V., Diaconu, I., Romano, V., Hirvinen, M., Ugolini, M., Escutenaire, S., Sirkka-Liisa, H., Kipar, A., Kanerva, A-M. & Hemminki, A., 1 nov 2012, I : Molecular therapy. 20, 11, s. 2076-2086 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Capsid-Modified Adenoviral Vectors for Improved Muscle-Directed Gene Therapy

Guse, K., Suzuki, M., Sule, G., Bertin, T. K., Tyynismaa, H., Ahola-Erkkila, S., Palmer, D., Suomalainen, A., Ng, P., Cerullo, V., Hemminki, A. & Lee, B., 1 okt 2012, I : Human Gene Therapy. 23, 10, s. 1065-1070 6 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review